Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05438043
Title A Study of Daratumumab
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

multiple myeloma

Therapies

Daratumumab + Dexamethasone + Lenalidomide

Daratumumab + Dexamethasone + Pomalidomide

Daratumumab

Carfilzomib + Daratumumab + Dexamethasone

Age Groups: adult | child | senior
Covered Countries USA | FRA | ESP | DEU


No variant requirements are available.